A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: Changes in psychiatric symptoms and substance use

Schizophrenia Research

Volumn 83, Issue 1, 2006, Pages 65-75

  Margolese, Howard C ^a,b   Carlos Negrete, Juan ^a,b   Tempier, Raymond ^a,b   Gill, Kathryn ^a,b,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Alcohol; Cannabis; Dual diagnosis; Psychosis; Schizophrenia; Substance use disorders

Indexed keywords

ADULT; ALCOHOLISM; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; MARIJUANA ABUSE; MULTIVARIATE ANALYSIS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 33645360873     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2005.11.019     Document Type: Article

References (43)

1. M.C. Angermeyer Schizophrenia and violence Acta Psychiatr. Scand., Suppl. 102 2000 63 67
2. S. Arndt, G. Tyrrell, M. Flaum, and N.C. Andreasen Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment Psychol. Med. 22 1992 379 388
3. F. Baker, and J. Intagliata Quality of life in the evaluation of community support systems Eval. Program Plann. 5 1982 69 79
4. S.J. Bartels, R.E. Drake, and M.A. Wallach Long-term course of substance use disorders among patients with severe mental illness Psychiatr. Serv. 46 1995 248 251
5. M. Bell, T. Greig, P. Gill, H. Whelahan, and G. Bryson Work rehabilitation and patterns of substance use among persons with schizophrenia Psychiatr. Serv. 53 2002 63 69
6. N.H. Bhanji, G. Chouinard, and H.C. Margolese A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia Eur. Neuropsychopharmacol. 14 2004 87 92
7. F.C. Blow, K.L. Barry, B.J. BootsMiller, L.A. Copeland, R. McCormick, and S. Visnic Longitudinal assessment of inpatient use and functioning of seriously mentally ill veterans with and without co-occurring substance use disorders J. Psychiatr. Res. 32 1998 311 319
8. B.J. BootsMiller, K.M. Ribisl, C.T. Mowbray, W.S. Davidson, M.A. Walton, and S.E. Herman Methods of ensuring high follow-up rates: lessons from a longitudinal study of dual diagnosed participants Subst. Use Misuse 33 1998 2665 2685
9. B. Buhler, M. Hambrecht, W. Loffler, H.W. an der, and H. Hafner Precipitation and determination of the onset and course of schizophrenia by substance abuse-a retrospective and prospective study of 232 population-based first illness episodes Schizophr. Res. 54 2002 243 251
10. D. Carise, A.T. McLellan, J. Cacciola, M. Love, T. Cook, G. Bovasso, and V. Lam Suggested specifications for a standardized Addiction Severity Index database J. Subst. Abuse Treat. 20 2001 239 244
11. D. Caspari Cannabis and schizophrenia: results of a follow-up study Eur. Arch. Psychiatry Clin. Neurosci. 249 1999 45 49
12. T.L. Chouljian, M. Shumway, E. Balancio, E.V. Dwyer, R. Surber, and M. Jacobs Substance use among schizophrenic outpatients: prevalence, course, and relation to functional status Ann. Clin. Psychiatry 7 1995 19 24
13. E.L. Coldham, J. Addington, and D. Addington Medication adherence of individuals with a first episode of psychosis Acta Psychiatr. Scand. 106 2002 286 290
14. L.R. Derogatis, and N. Melisaratos The Brief Symptom Inventory: an introductory report Psychol. Med. 13 1983 595 605
15. L. Dixon, G. Haas, P.J. Weiden, J. Sweeney, and A.J. Frances Drug abuse in schizophrenic patients: clinical correlates and reasons for use Am. J. Psychiatry 148 1991 224 230
16. L. Dixon, S. McNary, and A.F. Lehman Remission of substance use disorder among psychiatric inpatients with mental illness Am. J. Psychiatry 155 1998 239 243
17. R.E. Drake, F.C. Osher, and M.A. Wallach Alcohol use and abuse in schizophrenia. A prospective community study J. Nerv. Ment. Dis. 177 1989 408 414
18. R.E. Drake, K.T. Mueser, R.E. Clark, and M.A. Wallach The course, treatment, and outcome of substance disorder in persons with severe mental illness Am. J. Orthopsychiatry 66 1996 42 51
19. R.E. Drake, K.T. Mueser, M.F. Brunette, and G.J. McHugo A review of treatments for people with severe mental illnesses and co-occurring substance use disorders Psychiatr. Rehabil. J. 27 2004 360 374
20. N. el Guebaly, and D.C. Hodgins Schizophrenia and substance abuse: prevalence issues Can. J. Psychiatry 37 1992 704 710
21. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
22. J.L.B.R. Horley Affective and cognitive components of global subjective well-being measures Soc. Indic. Res. 17 1985 189 197
23. G.E. Hunt, J. Bergen, and M. Bashir Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse Schizophr. Res. 54 2002 253 264
24. C.C. Joyal, P. Halle, D. Lapierre, and S. Hodgins Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia Schizophr. Res. 63 2003 297 299
25. Kamali, M., Kelly, L., Gervin, M., Browne, S., Larkin, C., O'Callaghan, E., 2001. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr. Serv. 52, 161-3, 166.
26. R. Kamman, M. Farry, and P. Harbison The analysis and measurement of happiness as a sense of well-being Soc. Indic. Res. 15 1983 91 115
27. S.R. Kay, L.A. Opler, and J.P. Lindenmayer Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenics Psychiatry Res. 23 1988 99 110
28. S.R. Kay, L.A. Opler, and J.P. Lindenmayer The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation Br. J. Psychiatry Suppl. 1989 59 67
29. K.S. Kendler, T.J. Gallagher, J.M. Abelson, and R.C. Kessler Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey Arch. Gen. Psychiatry 53 1996 1022 1031
30. R.C. Kessler, K.A. McGonagle, S. Zhao, C.B. Nelson, M. Hughes, S. Eshleman, H.U. Wittchen, and K.S. Kendler Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch. Gen. Psychiatry 51 1994 8 19
31. R.J. Larsen, D. Diener, and R.A. Emmons An evaluation of subjective well-being measures Soc. Indic. Res. 17 1985 1 17
32. H.C. Margolese, L. Malchy, J.C. Negrete, R. Tempier, and K. Gill Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences Schizophr. Res. 67 2004 157 166
33. A.T. McLellan, L. Luborsky, G.E. Woody, and C.P. O'Brien An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index J. Nerv. Ment. Dis. 168 1980 26 33
34. A.T. McLellan, L. Luborsky, J. Cacciola, J. Griffith, F. Evans, H.L. Barr, and C.P. O'Brien New data from the Addiction Severity Index. Reliability and validity in three centers J. Nerv. Ment. Dis. 173 1985 412 423
35. C. Mercier, R. Tempier, and C. Renaud Community services and quality of life: a study of the impact in a remote region Can. J. Psychiatry 37 1992 553 563
36. J.C. Negrete, W.P. Knapp, D.E. Douglas, and W.B. Smith Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey Psychol. Med. 16 1986 515 520
37. M. Olfson, D. Mechanic, S. Hansell, C.A. Boyer, J. Walkup, and P.J. Weiden Predicting medication noncompliance after hospital discharge among patients with schizophrenia Psychiatr. Serv. 51 2000 216 222
38. J.E. Overall, and D.R. Gorman The brief psychiatric rating scale Psychol. Rep. 10 1962 799 802
39. A.E. Pulver, P.S. Wolyniec, M.G. Wagner, C.C. Moorman, and J.A. McGrath An epidemiologic investigation of alcohol-dependent schizophrenics Acta Psychiatr. Scand. 79 1989 603 612
40. D.A. Regier, M.E. Farmer, D.S. Rae, B.Z. Locke, S.J. Keith, L.L. Judd, and F.K. Goodwin Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study JAMA 264 1990 2511 2518
41. M.P. Salyers, and K.T. Mueser Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia Schizophr. Res. 48 2001 109 123
42. M. Soyka Substance misuse, psychiatric disorder and violent and disturbed behaviour Br. J. Psychiatry 176 2000 345 350
43. M.S. Swartz, J.W. Swanson, V.A. Hiday, R. Borum, H.R. Wagner, and B.J. Burns Violence and severe mental illness: the effects of substance abuse and nonadherence to medication Am. J. Psychiatry 155 1998 226 231